Comparison of two dosing regimens of vaginal misoprostol for labour induction

A randomised controlled trial

Shivarudraiah Girija, Attibele Palaksha Manjunath

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: To compare the clinical efficacy of two different dosing regimens of vaginal misoprostol for labour induction. Material and methods: This is an open label randomised controlled trial of 100 eligible women with obstetrical or medical indications for labour induction at a secondary level care hospital on the west coast of India. Women were randomised to receive either a single 50 μg dose or multiple 25 μg doses (maximum of three doses) of misoprostol in the posterior vaginal fornix. The main outcome measure was induction to vaginal delivery interval. Results: Mean induction delivery interval was 18.58±13.73 and 14.42±13.2 hours (P=0.73) in the 50 μg and 25 μg misoprostol group respectively. Delivery rate within 24 hours were 60% (30/50), in 50 μg group and 68% (34/50) in 25 μg group (P=0.53). The rates of caesarean section and operative vaginal delivery were similar in both groups. There was no significant difference in maternal side effects and neonatal outcome among regimens. Conclusion: There was no statistically significant difference between the two regimens in terms of clinical efficacy.

Original languageEnglish
Pages (from-to)220-225
Number of pages6
JournalJournal of the Turkish German Gynecology Association
Volume10
Issue number4
Publication statusPublished - 01-12-2009
Externally publishedYes

Fingerprint

Induced Labor
Misoprostol
Randomized Controlled Trials
Secondary Care
Cesarean Section
India
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Cite this

@article{1bfe75a586cf4f9ab97b67025dc3e10c,
title = "Comparison of two dosing regimens of vaginal misoprostol for labour induction: A randomised controlled trial",
abstract = "Objective: To compare the clinical efficacy of two different dosing regimens of vaginal misoprostol for labour induction. Material and methods: This is an open label randomised controlled trial of 100 eligible women with obstetrical or medical indications for labour induction at a secondary level care hospital on the west coast of India. Women were randomised to receive either a single 50 μg dose or multiple 25 μg doses (maximum of three doses) of misoprostol in the posterior vaginal fornix. The main outcome measure was induction to vaginal delivery interval. Results: Mean induction delivery interval was 18.58±13.73 and 14.42±13.2 hours (P=0.73) in the 50 μg and 25 μg misoprostol group respectively. Delivery rate within 24 hours were 60{\%} (30/50), in 50 μg group and 68{\%} (34/50) in 25 μg group (P=0.53). The rates of caesarean section and operative vaginal delivery were similar in both groups. There was no significant difference in maternal side effects and neonatal outcome among regimens. Conclusion: There was no statistically significant difference between the two regimens in terms of clinical efficacy.",
author = "Shivarudraiah Girija and Manjunath, {Attibele Palaksha}",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "10",
pages = "220--225",
journal = "Journal of the Turkish German Gynecology Association",
issn = "1309-0399",
publisher = "Aves",
number = "4",

}

Comparison of two dosing regimens of vaginal misoprostol for labour induction : A randomised controlled trial. / Girija, Shivarudraiah; Manjunath, Attibele Palaksha.

In: Journal of the Turkish German Gynecology Association, Vol. 10, No. 4, 01.12.2009, p. 220-225.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of two dosing regimens of vaginal misoprostol for labour induction

T2 - A randomised controlled trial

AU - Girija, Shivarudraiah

AU - Manjunath, Attibele Palaksha

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Objective: To compare the clinical efficacy of two different dosing regimens of vaginal misoprostol for labour induction. Material and methods: This is an open label randomised controlled trial of 100 eligible women with obstetrical or medical indications for labour induction at a secondary level care hospital on the west coast of India. Women were randomised to receive either a single 50 μg dose or multiple 25 μg doses (maximum of three doses) of misoprostol in the posterior vaginal fornix. The main outcome measure was induction to vaginal delivery interval. Results: Mean induction delivery interval was 18.58±13.73 and 14.42±13.2 hours (P=0.73) in the 50 μg and 25 μg misoprostol group respectively. Delivery rate within 24 hours were 60% (30/50), in 50 μg group and 68% (34/50) in 25 μg group (P=0.53). The rates of caesarean section and operative vaginal delivery were similar in both groups. There was no significant difference in maternal side effects and neonatal outcome among regimens. Conclusion: There was no statistically significant difference between the two regimens in terms of clinical efficacy.

AB - Objective: To compare the clinical efficacy of two different dosing regimens of vaginal misoprostol for labour induction. Material and methods: This is an open label randomised controlled trial of 100 eligible women with obstetrical or medical indications for labour induction at a secondary level care hospital on the west coast of India. Women were randomised to receive either a single 50 μg dose or multiple 25 μg doses (maximum of three doses) of misoprostol in the posterior vaginal fornix. The main outcome measure was induction to vaginal delivery interval. Results: Mean induction delivery interval was 18.58±13.73 and 14.42±13.2 hours (P=0.73) in the 50 μg and 25 μg misoprostol group respectively. Delivery rate within 24 hours were 60% (30/50), in 50 μg group and 68% (34/50) in 25 μg group (P=0.53). The rates of caesarean section and operative vaginal delivery were similar in both groups. There was no significant difference in maternal side effects and neonatal outcome among regimens. Conclusion: There was no statistically significant difference between the two regimens in terms of clinical efficacy.

UR - http://www.scopus.com/inward/record.url?scp=75749086475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749086475&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 220

EP - 225

JO - Journal of the Turkish German Gynecology Association

JF - Journal of the Turkish German Gynecology Association

SN - 1309-0399

IS - 4

ER -